Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
33.70    -2.10 (-5.87%)
Bid:
33.70
Ask:
34.50
Spread: 0.80 (2.374%)
Market Cap: £24.74m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Year End Trading Update

9 Apr 2015 07:00

RNS Number : 6739J
Carclo plc
09 April 2015
 

For immediate release

9 April 2015

 

Carclo plc

("Carclo" or the "Group")

 

Year End Trading Update

 

The Board is pleased to announce that the Group has traded in line with its expectations for the financial year ended 31 March 2015.

 

Technical Plastics has benefitted from a strong last quarter and margins in this division continue to increase as high quality new programs are integrated in our global operations. Our capacity expansions in the US and Czech Republic are now complete and we expect our new facility in China will become fully operational during the new financial year. We have also started to increase capacity in India and at Tucson in the US with the securing of additional leased facilities. Overall these expansions will facilitate our continued growth in our key regions.

 

The LED Technologies division has also experienced a stronger second half at both Wipac and its LED Optics business. Wipac has continued to win additional supercar lighting programs and its recent capacity upgrade will facilitate the further growth we expect in this business.

 

Our Precision Engineering division has had a good year and we anticipate further moderate growth in this business in the new financial year.

 

Progress at Carclo Diagnostic Solutions has been encouraging with advances in microfluidics and plastics optimisation providing an increasingly strong underpinning for our Micropoc platforms. We have undertaken a third party commercialisation review which has resulted in an increased focus on the Troponin and CRP applications as these present the greatest commercially viable opportunities.

 

In October 2014, we announced that we had commenced a strategic review of our CIT Technology ("CIT") business. Over the last few months the Board has been considering all options for CIT ranging from our continued ownership through to a possible sale or licensing of the technology. To this end, we appointed corporate advisors to assist the Board in this process; to date we have seen some interest and discussions with potential acquirers remain ongoing. Regardless of the outcome of this, the Board intends that the Group will exit the CIT Touch and Printed Electronics businesses. CIT is still supporting last time purchases of product from its partner, Atmel Corporation, and will continue to manufacture coated film for approximately a further six months. This ongoing supply should not have any materially negative financial impact on the Group in the new financial year.

 

As previously announced, the Group's refinancing project is now complete and a new five year multi-currency revolving facility of £30.0 million has been agreed with HSBC.

 

The Board remains confident in the Group's strategy and is encouraged by the significant future growth prospects of its two main divisions. 

 

Carclo will announce its preliminary results for the year ended 31 March 2015 on 9 June 2015.

 

- ENDS -

 

Enquiries:

 

Carclo plc

 

01924 268040

Chris Malley, Chief Executive

 

 

Robert Brooksbank, Finance Director

 

 

 

 

 

Peel Hunt LLP

 

0207 418 8900

Justin Jones

 

 

Jock Maxwell Macdonald

 

 

Mike Bell

 

 

 

N+1 Singer

Shaun Dobson

Richard Lindley

 

 

 

020 7496 3000

Weber Shandwick

Nick Oborne

Tom Jenkins

 

020 7067 0000

 

Notes to editors

 

Carclo plc is a public company whose shares are quoted on the London Stock Exchange.

 

Carclo's strategy is to develop and expand its key manufacturing assets where there remain significant further opportunities to drive value. To enhance profit margins the group has been investing in new technologies.

 

Approximately three fifths of revenues are currently derived from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the low volume premium automotive industry.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSWFAAFISEIL
Date   Source Headline
29th Apr 20264:59 pmRNSDirector Dealing – Late Notification
27th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 202610:34 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSTrading Update
24th Dec 202510:10 amRNSDirector/PDMR Shareholding
24th Dec 202510:10 amRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSDirector/PDMR Shareholding
21st Nov 20257:00 amRNSHalf-year Financial Report
17th Nov 20257:00 amRNSNotice of Half Year Results
30th Sep 20256:20 pmRNSDirector/PDMR Shareholding
30th Sep 20256:14 pmRNSDirector/PDMR Shareholding
26th Sep 202512:30 pmRNSResult of AGM
26th Sep 20257:00 amRNSTrading Update
19th Sep 20255:58 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSChange of Auditor
11th Sep 20258:41 amRNSDirector/PDMR Shareholding
1st Sep 20257:30 amRNSRestoration - Carclo PLC
29th Aug 202511:55 amRNSNotice of AGM
29th Aug 20257:00 amRNSFull Year 2025 audited results
28th Aug 20257:00 amRNSNotice of Results and Investor Presentation
1st Aug 20257:30 amRNSSuspension - Carclo PLC
17th Jul 20254:42 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSContract renewal strengthens revenue visibility
10th Jul 20257:00 amRNSTrading Statement & Delay in 2025 Audited Results
2nd May 202511:33 amRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Statement
28th Apr 20255:06 pmRNSHolding(s) in Company
24th Apr 20254:02 pmRNSRefinancing Arrangements, Pension Scheme Valuation
3rd Apr 20257:00 amRNSHolding(s) in Company
6th Mar 202510:43 amRNSHolding(s) in Company
18th Feb 20255:10 pmRNSHolding(s) in Company
13th Feb 20257:00 amRNSCFO Appointment
19th Dec 20243:49 pmRNSHolding(s) in Company
5th Dec 20247:00 amRNSInterim Report and Accounts 30 September 2024
12th Nov 202411:11 amRNSNotice of Interim Results & Investor Presentation
10th Sep 20249:33 amRNSHolding(s) in Company
5th Sep 20241:30 pmRNSResult of AGM
5th Sep 20247:00 amRNSTrading Update
16th Aug 202412:32 pmRNSHolding(s) in Company
5th Aug 202412:11 pmRNSHolding(s) in Company
31st Jul 202410:00 amRNS2024 Annual Report & Accounts and Notice of AGM
30th Jul 20243:21 pmRNSHolding(s) in Company
24th Jul 20242:49 pmRNSHolding(s) in Company
24th Jul 202412:57 pmRNSHolding(s) in Company
23rd Jul 20243:48 pmRNSHolding(s) in Company
23rd Jul 20241:08 pmRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSFinal Results
17th Jul 20241:07 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSNotice of Results
8th Jul 20248:51 amRNSBank Facilities Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.